Golezar, Samira
Keshavarz, Zohreh
Ramezani Tehrani, Fahimeh
Ebadi, Abbas
Zayeri, Farid
Golezar, Mohammad Hossein
Article History
Received: 17 February 2022
Accepted: 11 October 2022
First Online: 28 November 2022
Declarations
:
: This study was approved by the ethics committee of Shahid Beheshti University of Medical Sciences, with approval number IR.SBMU.PHARMACY.REC.1399.194. Informed written consent was obtained from all individual participants included in the study. All methods performed in accordance with the relevant guidelines and regulations. e.g., the Declaration of Helsinki.
: Not applicable.
: Authors declare that they have no competing interests.